Share on StockTwits

Hill-Rom Holdings (NYSE:HRC) was upgraded by Goldman Sachs from a “neutral” rating to a “buy” rating in a research note issued on Wednesday, reports.

Other equities research analysts have also recently issued reports about the stock. Analysts at Piper Jaffray raised their price target on shares of Hill-Rom Holdings from $40.00 to $43.00 in a research note on Wednesday. Separately, analysts at Morgan Stanley reiterated an “underweight” rating on shares of Hill-Rom Holdings in a research note on Friday, May 2nd. They now have a $36.00 price target on the stock. Finally, analysts at Northcoast Research downgraded shares of Hill-Rom Holdings from a “buy” rating to a “neutral” rating in a research note on Friday, April 11th. One analyst has rated the stock with a sell rating, six have given a hold rating and one has given a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $41.97.

Shares of Hill-Rom Holdings (NYSE:HRC) traded up 0.95% during mid-day trading on Wednesday, hitting $40.59. The stock had a trading volume of 228,373 shares. Hill-Rom Holdings has a 1-year low of $32.85 and a 1-year high of $44.64. The stock has a 50-day moving average of $39. and a 200-day moving average of $38.92. The company has a market cap of $2.323 billion and a price-to-earnings ratio of 34.69.

Hill-Rom Holdings (NYSE:HRC) last issued its quarterly earnings data on Friday, May 2nd. The company reported $0.57 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.51 by $0.06. The company had revenue of $415.00 million for the quarter, compared to the consensus estimate of $412.02 million. During the same quarter in the prior year, the company posted $0.49 earnings per share. The company’s quarterly revenue was down 2.4% on a year-over-year basis. Analysts expect that Hill-Rom Holdings will post $2.23 EPS for the current fiscal year.

Hill-Rom Holdings, Inc (NYSE:HRC) is a manufacturer and provider of medical technologies and related services for the health care industry, including patient care systems, safe mobility and handling solutions, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals, surgical products and information technology solutions.

The Fly On The Wall

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.